Pharmena S.A.

PHR

PLPHRMN00011

Personal Products

Market Closed - Warsaw S.E. Other stock markets 11:55:44 2024-05-17 am EDT			5-day change	1st Jan Change
6.44 ^PLN	+1.26%		-2.72%	-9.30%

Feb. 29	Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna.

December 02, 2013 at 11:00 pm EST

Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna (WSE:PHR) on November 29, 2013. Under the terms of the transaction, Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. increased the stake held from 0.26 million shares to 0.61 million shares representing 6.91% stake in Pharmena Spolka Akcyjna.

Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. completed the acquisition of additional 3.98% stake in Pharmena Spolka Akcyjna (WSE:PHR) on November 29, 2013.

Latest news about Pharmena S.A.

Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 27	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Grupo AC MARCA SL entered into an agreement to acquire Dermena from Pharmena S.A.	23-07-17	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-25	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-27	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-26	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-12	CI
Pharmena S.A. announced that it has received PLN 15.0858 million in funding from Pelion S.A.	20-11-29	CI
Pharmena S.A. announced that it expects to receive funding from Pelion S.A.	20-10-08	CI
Pharmena S.A. announced that it expects to receive PLN 0.299998 million in funding	18-08-28	CI
Cortria Corporation announced that it has received $0.2 million in funding from Pharmena S.A.	18-05-28	CI
Cortria Corporation announced that it has received $0.3 million in funding from Pharmena S.A.	17-10-29	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	17-04-24	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. sold 6.91% stake in Pharmena Spolka Akcyjna.	16-12-27	CI
Pelion S.A. acquired an additional 6.91% stake in Pharmena Spolka Akcyjna.	16-12-26	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	16-08-23	CI
Pharmena SA Announces Earnings Results for the First Quarter of 2016	16-05-13	CI
Pelion S.A. acquired an additional 4.09% stake in Pharmena Spolka Akcyjna.	15-12-27	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna.	13-12-02	CI

Chart Pharmena S.A.

Duration

Period

More charts

Company Profile

Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Companyâs products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Sector

Personal Products

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
PHARMENA S.A.	-9.30%	18.08M
L'ORÉAL	-0.68%	264B
KAO CORPORATION	+19.72%	20.89B
GALDERMA GROUP AG	0.00%	19.67B
SHISEIDO COMPANY, LIMITED	+15.62%	12.52B
COTY INC.	-14.17%	9.53B
AMOREPACIFIC CORPORATION	+19.93%	8.03B
PROYA COSMETICS CO.,LTD.	+10.20%	6.01B
NATURA &CO HOLDING S.A.	-2.43%	4.49B
INTER PARFUMS, INC.	-13.55%	4.01B

Cosmetics & Perfumes

Pharmena S.A.

Equities

PHR

PLPHRMN00011

Personal Products

Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna.

Latest news about Pharmena S.A.

Chart Pharmena S.A.

Company Profile

Income Statement Evolution

Sector Cosmetics & Perfumes